Jeffrey Fuller

Associate Professor
Division of Diagnostic and Applied Microbiology
2B3.12 Walter Mackenzie Health Sciences Centre
8440-112 Street
Edmonton, Alberta, Canada T6G 2R7
Tel: 780.407.2767


EDUCATION:  2006 FCCM, (D)ABMM; 2003 PhD.
Clinical:  Antimicrobial stewardship and detection/surveillance of resistance
Educational:  Microbial diagnostics, advanced identification, and quality management

  • Development and optimization of antifungal susceptibility test methods, particularly filamentous fungi 
  • Development of software application for automated production of cumulative antibiograms​


  • E. Bow, G. Evans, J. Fuller, M. Laverdiere, C. Rotstein, R. Rennie, S. Shafran, D. Sheppard, S. Carle, P. Phillips, D. Vihn.  Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults.  Can. J. Infect. Dis. Med. Microbiol.  2010; In Press.
  • J. Fuller, A. Schofield, S. Jiwa, C. Sand, B. Jansen, R. Rennie.  Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.  J. Clin Microbiol. 2010; 48(2). 
  • M. McCracken, M. DeCorby, J. Fuller, V. Loo, D. Hoban, G. Zhanel, and M. Mulvey.  Identification of multi-drug & carbapenem-resistent Acinetobacter baumannii in Canada: Results from CANWARD 2007. J Antimicrob Chemother. 2009.
  • J. Carson, B. Lui, L. Rosmus, H. Rennick, and J. Fuller. Interpretation of MRSA Select screening agar at 24 hours of incubation. J Clin Microbiol. 2009; 47(3):566-568. 
  • H. Tien, A. Battad, E. Bryce, J. Fuller, M. Mulvey, K. Bernard, R. Brisebois, J. Doucet, S. Rizoli, R. Fowler, and A. Simor.  Multi-drug resistant Acinetobacter infections in critically injured Canadian Forces soldiers. BMC Infect Dis. 2007:7(1):95.